{
    "xml": "<topic id=\"PHP80616\" outputclass=\"drug\" rev=\"1.24\" type=\"drug\" namespace=\"/drugs/haloperidol-decanoate\" basename=\"haloperidol-decanoate\" title=\"HALOPERIDOL DECANOATE\">\n<title>HALOPERIDOL DECANOATE</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_387\" namespace=\"/interactions/list-of-drug-interactions/antipsychotics/butyrophenones/haloperidol\">Haloperidol</xref>\n</p>\n<data name=\"vtmid\">321699007</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_716774613\" title=\"Antipsychotics (first-generation, depot injections)\">Antipsychotics (first-generation, depot injections)</xref>\n</data>\n<data name=\"inheritsFromClass\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34569\" title=\"ANTIPSYCHOTIC DRUGS\" namespace=\"/drug-classes/antipsychotic-drugs\">ANTIPSYCHOTIC DRUGS</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP80762\" outputclass=\"indicationsAndDose\" rev=\"1.11\" parent=\"/drugs/haloperidol-decanoate\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Maintenance in schizophrenia and other psychoses</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By deep intramuscular injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 50&#8239;mg every 4&#8239;weeks, increased in steps of 50&#8239;mg if required, increased if necessary up to 300&#8239;mg every 4&#8239;weeks, higher doses may be needed in some patients, dose to be administered into gluteal muscle, if 2-weekly administration preferred, doses should be halved.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Elderly</p>\n<p>Initially 12.5&#8211;25&#8239;mg every 4&#8239;weeks, if 2-weekly administration preferred, doses should be halved.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"doseAdjustments\">\n<title>Dose adjustments due to interactions</title>\n<sectiondiv>\n<p>Dose adjustment may be necessary if smoking started or stopped during treatment.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP80758\" outputclass=\"importantSafetyInformation\" rev=\"1.9\" parent=\"/drugs/haloperidol-decanoate\">\n<title>Important safety information</title>\n<body>\n<section>\n<sectiondiv>\n<p>When prescribing, dispensing or administering, check that this is the correct preparation&#8212;this preparation is used for <i>maintenance</i> treatment and should <b>not</b> be used for the rapid control of an <i>acute episode</i>.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP80757\" outputclass=\"contraindications\" rev=\"1.18\" parent=\"/drugs/haloperidol-decanoate\">\n<title>Contra-indications</title>\n<body>\n<section outputclass=\"contraindications\">\n<p>\n<ph outputclass=\"contraindication\">Bradycardia</ph>; <ph outputclass=\"contraindication\">children</ph>; <ph outputclass=\"contraindication\">CNS depression</ph>; <ph outputclass=\"contraindication\">comatose states</ph>; <ph outputclass=\"contraindication\">lesions of the basal ganglia</ph>; <ph outputclass=\"contraindication\">Parkinson's disease</ph>; <ph outputclass=\"contraindication\">phaeochromocytoma</ph>; <ph outputclass=\"contraindication\">QT-interval prolongation</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP80755\" outputclass=\"cautions\" rev=\"1.15\" parent=\"/drugs/haloperidol-decanoate\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">Arteriosclerosis</ph>; <ph outputclass=\"caution\">hypocalcaemia</ph>; <ph outputclass=\"caution\">hypokalaemia</ph>; <ph outputclass=\"caution\">hypomagnesaemia</ph>; <ph outputclass=\"caution\">metabolic disturbances</ph>; <ph outputclass=\"caution\">subarachnoid haemorrhage</ph>; <ph outputclass=\"caution\">thyrotoxicosis</ph>; <ph outputclass=\"caution\">when transferring from oral to depot therapy, the dose by mouth should be reduced gradually</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP80763\" outputclass=\"interactions\" rev=\"1.17\" parent=\"/drugs/haloperidol-decanoate\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Avoid concomitant administration of drugs that prolong QT interval.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP80768\" outputclass=\"sideEffects\" rev=\"1.16\" parent=\"/drugs/haloperidol-decanoate\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"commonOrVeryCommon\">\n<p outputclass=\"title\">Common or very common</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Depression</ph>; <ph outputclass=\"sideEffect\">weight loss</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"uncommon\">\n<p outputclass=\"title\">Uncommon</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Dyspnoea</ph>; <ph outputclass=\"sideEffect\">oedema</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"rare\">\n<p outputclass=\"title\">Rare</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Bronchospasm</ph>; <ph outputclass=\"sideEffect\">hypoglycaemia</ph>; <ph outputclass=\"sideEffect\">inappropriate antidiuretic hormone secretion</ph>; <ph outputclass=\"sideEffect\">photosensitivity reactions</ph>; <ph outputclass=\"sideEffect\">pigmentation</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Erythema</ph>; <ph outputclass=\"sideEffect\">hypertension</ph>; <ph outputclass=\"sideEffect\">nodules</ph>; <ph outputclass=\"sideEffect\">pain may occur at injection site</ph>; <ph outputclass=\"sideEffect\">Stevens-Johnson syndrome</ph>; <ph outputclass=\"sideEffect\">sweating</ph>; <ph outputclass=\"sideEffect\">swelling</ph>; <ph outputclass=\"sideEffect\">toxic epidermal necrolysis</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n<section outputclass=\"sideEffectsAdvice\">\n<title>Side-effects, further information</title>\n<sectiondiv>\n<p>Less sedating and fewer antimuscarinic or hypotensive symptoms.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP80764\" outputclass=\"pregnancy\" parent=\"/drugs/haloperidol-decanoate\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Avoid unless benefits outweigh risk.</p>\n<p>Extrapyramidal effects and withdrawal syndrome have been reported occasionally in the neonate when antipsychotic drugs are taken during the third trimester of pregnancy.</p>\n<p>Following maternal use of antipsychotic drugs in the third trimester, neonates should be monitored for symptoms including agitation, hypertonia, hypotonia, tremor, drowsiness, feeding problems, and respiratory distress.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP80754\" outputclass=\"breastFeeding\" parent=\"/drugs/haloperidol-decanoate\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>There is limited information available on the short- and long-term effects of antipsychotic drugs on the breast-fed infant.</p>\n<p>\n<i>Animal</i> studies indicate possible adverse effects of antipsychotic medicines on the developing nervous system. Chronic treatment with antipsychotic drugs whilst breast-feeding should be avoided unless absolutely necessary.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP80761\" outputclass=\"hepaticImpairment\" parent=\"/drugs/haloperidol-decanoate\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Can precipitate coma.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP80766\" outputclass=\"renalImpairment\" parent=\"/drugs/haloperidol-decanoate\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"doseAdjustments\">\n<sectiondiv>\n<p>Start with small doses in severe renal impairment because of increased cerebral sensitivity.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP80772\" outputclass=\"monitoringRequirements\" parent=\"/drugs/haloperidol-decanoate\">\n<title>Monitoring requirements</title>\n<body>\n<section outputclass=\"monitoringOfPatientParameters\">\n<sectiondiv>\n<p>Treatment requires careful monitoring for optimum effect.</p>\n<p>Baseline ECG required before treatment&#8212;assess need for further ECGs during treatment on an individual basis.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP80752\" outputclass=\"directionsForAdministration\" rev=\"1.11\" parent=\"/drugs/haloperidol-decanoate\">\n<title>Directions for administration</title>\n<body>\n<section>\n<sectiondiv>\n<p>In general not more than 2&#8211;3&#8239;mL of oily injection should be administered at any one site.</p>\n<p>Correct injection technique (including use of z-track technique) and rotation of injection sites are essential.</p>\n<p>When initiating therapy with sustained-release preparations of conventional antipsychotics, patients should first be given a small test-dose as undesirable side-effects are prolonged.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP80616-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/haloperidol-decanoate\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP92190\" title=\"Solution for injection\" namespace=\"/drugs/haloperidol-decanoate/solution-for-injection\">Solution for injection</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_387\" namespace=\"/interactions/list-of-drug-interactions/antipsychotics/butyrophenones/haloperidol\" title=\"Haloperidol\" count=\"1\" rel=\"link\">Haloperidol</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34569\" namespace=\"/drug-classes/antipsychotic-drugs\" title=\"ANTIPSYCHOTIC DRUGS\" count=\"1\" rel=\"link\">ANTIPSYCHOTIC DRUGS</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP92190\" namespace=\"/drugs/haloperidol-decanoate/solution-for-injection\" title=\"Solution for injection\" count=\"1\" rel=\"link\">Solution for injection</xref>\n</links>\n</topic>",
    "id": "PHP80616",
    "outputclass": "drug",
    "rev": "1.24",
    "type": "drug",
    "namespace": "/drugs/haloperidol-decanoate",
    "basename": "haloperidol-decanoate",
    "title": "HALOPERIDOL DECANOATE",
    "interactants": [
        {
            "id": "bnf_int_387",
            "label": "Haloperidol"
        }
    ],
    "vtmid": "321699007",
    "drugClassification": [
        "Antipsychotics (first-generation, depot injections)"
    ],
    "inheritsFromClass": [
        "ANTIPSYCHOTIC DRUGS"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Maintenance in schizophrenia and other psychoses",
                        "html": "Maintenance in schizophrenia and other psychoses"
                    }
                ],
                "specificity": {
                    "routes": [
                        "deep intramuscular injection"
                    ],
                    "textContent": "By deep intramuscular injection",
                    "html": "By deep intramuscular injection"
                },
                "adult": [
                    {
                        "textContent": "Initially 50 mg every 4 weeks, increased in steps of 50 mg if required, increased if necessary up to 300 mg every 4 weeks, higher doses may be needed in some patients, dose to be administered into gluteal muscle, if 2-weekly administration preferred, doses should be halved.",
                        "html": "<p>Initially 50&#8239;mg every 4&#8239;weeks, increased in steps of 50&#8239;mg if required, increased if necessary up to 300&#8239;mg every 4&#8239;weeks, higher doses may be needed in some patients, dose to be administered into gluteal muscle, if 2-weekly administration preferred, doses should be halved.</p>"
                    },
                    {
                        "textContent": "Initially 12.5&#8211;25 mg every 4 weeks, if 2-weekly administration preferred, doses should be halved.",
                        "html": "<p>Initially 12.5&#8211;25&#8239;mg every 4&#8239;weeks, if 2-weekly administration preferred, doses should be halved.</p>",
                        "ageGroup": "elderly"
                    }
                ]
            }
        ],
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "title": "Dose adjustments due to interactions",
                "textContent": "Dose adjustment may be necessary if smoking started or stopped during treatment.",
                "html": "<p>Dose adjustment may be necessary if smoking started or stopped during treatment.</p>"
            }
        ]
    },
    "importantSafetyInformation": {
        "importantSafetyInformation": [
            {
                "type": "importantSafetyInformation",
                "textContent": "When prescribing, dispensing or administering, check that this is the correct preparation&#8212;this preparation is used for maintenance treatment and should not be used for the rapid control of an acute episode.",
                "html": "<p>When prescribing, dispensing or administering, check that this is the correct preparation&#8212;this preparation is used for <i>maintenance</i> treatment and should <b>not</b> be used for the rapid control of an <i>acute episode</i>.</p>"
            }
        ]
    },
    "contraindications": {
        "contraindications": [
            {
                "type": "contraindications",
                "textContent": "Bradycardia",
                "html": "Bradycardia"
            },
            {
                "type": "contraindications",
                "textContent": "children",
                "html": "children"
            },
            {
                "type": "contraindications",
                "textContent": "CNS depression",
                "html": "CNS depression"
            },
            {
                "type": "contraindications",
                "textContent": "comatose states",
                "html": "comatose states"
            },
            {
                "type": "contraindications",
                "textContent": "lesions of the basal ganglia",
                "html": "lesions of the basal ganglia"
            },
            {
                "type": "contraindications",
                "textContent": "Parkinson's disease",
                "html": "Parkinson's disease"
            },
            {
                "type": "contraindications",
                "textContent": "phaeochromocytoma",
                "html": "phaeochromocytoma"
            },
            {
                "type": "contraindications",
                "textContent": "QT-interval prolongation",
                "html": "QT-interval prolongation"
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Arteriosclerosis",
                "html": "Arteriosclerosis"
            },
            {
                "type": "cautions",
                "textContent": "hypocalcaemia",
                "html": "hypocalcaemia"
            },
            {
                "type": "cautions",
                "textContent": "hypokalaemia",
                "html": "hypokalaemia"
            },
            {
                "type": "cautions",
                "textContent": "hypomagnesaemia",
                "html": "hypomagnesaemia"
            },
            {
                "type": "cautions",
                "textContent": "metabolic disturbances",
                "html": "metabolic disturbances"
            },
            {
                "type": "cautions",
                "textContent": "subarachnoid haemorrhage",
                "html": "subarachnoid haemorrhage"
            },
            {
                "type": "cautions",
                "textContent": "thyrotoxicosis",
                "html": "thyrotoxicosis"
            },
            {
                "type": "cautions",
                "textContent": "when transferring from oral to depot therapy, the dose by mouth should be reduced gradually",
                "html": "when transferring from oral to depot therapy, the dose by mouth should be reduced gradually"
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Avoid concomitant administration of drugs that prolong QT interval.",
                "html": "<p>Avoid concomitant administration of drugs that prolong QT interval.</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "commonOrVeryCommon": [
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "Depression",
                        "html": "Depression",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "weight loss",
                        "html": "weight loss",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    }
                ],
                "uncommon": [
                    {
                        "type": "uncommon",
                        "textContent": "Dyspnoea",
                        "html": "Dyspnoea",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "oedema",
                        "html": "oedema",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    }
                ],
                "rare": [
                    {
                        "type": "rare",
                        "textContent": "Bronchospasm",
                        "html": "Bronchospasm",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "hypoglycaemia",
                        "html": "hypoglycaemia",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "inappropriate antidiuretic hormone secretion",
                        "html": "inappropriate antidiuretic hormone secretion",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "photosensitivity reactions",
                        "html": "photosensitivity reactions",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "pigmentation",
                        "html": "pigmentation",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    }
                ],
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Erythema",
                        "html": "Erythema",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "hypertension",
                        "html": "hypertension",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "nodules",
                        "html": "nodules",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "pain may occur at injection site",
                        "html": "pain may occur at injection site",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "Stevens-Johnson syndrome",
                        "html": "Stevens-Johnson syndrome",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "sweating",
                        "html": "sweating",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "swelling",
                        "html": "swelling",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "toxic epidermal necrolysis",
                        "html": "toxic epidermal necrolysis",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        },
        "advice": [
            {
                "type": "advice",
                "textContent": "Less sedating and fewer antimuscarinic or hypotensive symptoms.",
                "html": "<p>Less sedating and fewer antimuscarinic or hypotensive symptoms.</p>"
            }
        ]
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Avoid unless benefits outweigh risk.\n\nExtrapyramidal effects and withdrawal syndrome have been reported occasionally in the neonate when antipsychotic drugs are taken during the third trimester of pregnancy.\n\nFollowing maternal use of antipsychotic drugs in the third trimester, neonates should be monitored for symptoms including agitation, hypertonia, hypotonia, tremor, drowsiness, feeding problems, and respiratory distress.",
                "html": "<p>Avoid unless benefits outweigh risk.</p><p>Extrapyramidal effects and withdrawal syndrome have been reported occasionally in the neonate when antipsychotic drugs are taken during the third trimester of pregnancy.</p><p>Following maternal use of antipsychotic drugs in the third trimester, neonates should be monitored for symptoms including agitation, hypertonia, hypotonia, tremor, drowsiness, feeding problems, and respiratory distress.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "There is limited information available on the short- and long-term effects of antipsychotic drugs on the breast-fed infant.\n\nAnimal studies indicate possible adverse effects of antipsychotic medicines on the developing nervous system. Chronic treatment with antipsychotic drugs whilst breast-feeding should be avoided unless absolutely necessary.",
                "html": "<p>There is limited information available on the short- and long-term effects of antipsychotic drugs on the breast-fed infant.</p><p>\n<i>Animal</i> studies indicate possible adverse effects of antipsychotic medicines on the developing nervous system. Chronic treatment with antipsychotic drugs whilst breast-feeding should be avoided unless absolutely necessary.</p>"
            }
        ]
    },
    "hepaticImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Can precipitate coma.",
                "html": "<p>Can precipitate coma.</p>"
            }
        ]
    },
    "renalImpairment": {
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "textContent": "Start with small doses in severe renal impairment because of increased cerebral sensitivity.",
                "html": "<p>Start with small doses in severe renal impairment because of increased cerebral sensitivity.</p>"
            }
        ]
    },
    "monitoringRequirements": {
        "patientParameters": [
            {
                "type": "patientParameters",
                "textContent": "Treatment requires careful monitoring for optimum effect.\n\nBaseline ECG required before treatment&#8212;assess need for further ECGs during treatment on an individual basis.",
                "html": "<p>Treatment requires careful monitoring for optimum effect.</p><p>Baseline ECG required before treatment&#8212;assess need for further ECGs during treatment on an individual basis.</p>"
            }
        ]
    },
    "directionsForAdministration": {
        "directionsForAdministration": [
            {
                "type": "directionsForAdministration",
                "textContent": "In general not more than 2&#8211;3 mL of oily injection should be administered at any one site.\n\nCorrect injection technique (including use of z-track technique) and rotation of injection sites are essential.\n\nWhen initiating therapy with sustained-release preparations of conventional antipsychotics, patients should first be given a small test-dose as undesirable side-effects are prolonged.",
                "html": "<p>In general not more than 2&#8211;3&#8239;mL of oily injection should be administered at any one site.</p><p>Correct injection technique (including use of z-track technique) and rotation of injection sites are essential.</p><p>When initiating therapy with sustained-release preparations of conventional antipsychotics, patients should first be given a small test-dose as undesirable side-effects are prolonged.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP92190",
                "label": "Solution for injection",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_387",
                "label": "Haloperidol",
                "type": "interaction"
            }
        ],
        "drugClass": [
            {
                "id": "PHP34569",
                "label": "ANTIPSYCHOTIC DRUGS",
                "type": "drugClass"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP92190",
                "label": "Solution for injection",
                "type": "medicinalForm"
            }
        ]
    }
}